GI Dynamics is an exciting and rapidly expanding company in the Boston area. We are focused on developing new therapies for the treatment of Obesity and Diabetes. GI Dynamics is pioneering the approach of noninvasive metabolic control through novel removable devices that modify metabolic pathways. Founded in 2003, GI Dynamics is developing its patented EndoBarrier™ technology to address the epidemic of metabolic diseases such as obesity and diabetes. GI Dynamics has raised $46 million in three rounds from top-tier venture capital companies including Advanced Technology Ventures, Cutlass Capital, Domain Associates, Johnson & Johnson Development Corporation and Polaris Venture Partners. The company has also assembled a world class group of advisors with specialties in bariatric surgery, gastroenterology, endocrinology and medical weight loss.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 07/01/03 | Series A | 4.1M | Unknown | |
| 05/01/04 | Series B | 12M | Unknown |